Companies Cryptocurrencies
Unum Therapeutics Inc
Unum Therapeutics Inc
Exchange: NasdaqGS
IPO Date: 29/03/2018
CEO: Dr. Charles Wilson
Biotechnology Healthcare đŸ”—
  • UMRX
    symbol
  • price
  • market cap
  • changes
If you bought

shares of Unum Therapeutics Inc (UMRX) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Unum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 56 full-time employees. The firm is focused on the developing and commercializing of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. Its proprietary technology, called antibody-coupled T cell receptor (ACTR), is a universal, engineered cell therapy that is used in combination with a range of tumor-specific antibodies to target different tumor types. The firm’s product candidates are composed of ACTR T cells co-administered with approved and commercially available antibodies or antibodies in preclinical or clinical development. The ACTR platform to transform cancer treatment and deliver patient cures in many different hematologic and solid tumor cancers, improving upon current cell therapies. The firm’s product pipeline that includes clinical stage product candidates: ACTR087, ACTR087 (SEA-BCMA) and ACTR707.

Address: 200 Cambridgepark Dr Ste 3100 Cambridge MASSACHUSETTS 02140

Stay updated.